Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Pro Fin Capital Services Reports Four-Fold Profit Jump, Announces 1:1 Bonus Issue

Banking/Finance

|

Updated on 07 Nov 2025, 12:33 pm

Whalesbook Logo

Reviewed By

Aditi Singh | Whalesbook News Team

Short Description:

Pro Fin Capital Services Ltd. reported a substantial 301% increase in net profit for the September quarter, reaching Rs 13.37 crore from Rs 2.46 crore in the previous year. Revenue from operations grew by 26.5% year-on-year to Rs 13.39 crore. The company's board also approved a 1:1 bonus issue, signaling confidence in its business outlook and commitment to rewarding shareholders.
Pro Fin Capital Services Reports Four-Fold Profit Jump, Announces 1:1 Bonus Issue

▶

Stocks Mentioned:

Pro Fin Capital Services Ltd.

Detailed Coverage:

Pro Fin Capital Services Ltd. announced robust financial results for the second quarter of FY 2025-26. The company's net profit surged by over 300%, jumping four-fold to Rs 13.37 crore compared to Rs 2.46 crore in the same period last year. Revenue from operations saw a significant increase of 26.5%, rising to Rs 13.39 crore from Rs 10.59 crore year-on-year. Total income also showed a dramatic rise to Rs 42.62 crore from Rs 6.69 crore.

For the first half of FY26, revenue from operations stood at Rs 17.93 crore, a 13% increase over the Rs 15.82 crore recorded in H1FY25.

Abhay Gupta, Director at Pro Fin Capital Services Ltd., stated that the company is focused on expanding its trading, credit, and advisory services, aiming for sustained long-term growth through strategic capital allocation and strong risk management.

Furthermore, the board of directors has approved a 1:1 bonus issue. This means shareholders will receive one additional share for every share they currently hold. This move is often seen as a sign of the company's financial health and its confidence in future prospects, aiming to increase liquidity and shareholder value.

Impact: This news is highly positive for Pro Fin Capital Services and its shareholders. The significant profit growth indicates strong operational performance, while the bonus issue is expected to boost investor confidence and potentially increase the stock's liquidity and attractiveness. It suggests a healthy business environment for the company. The impact on the company's stock could be positive, with potential for increased trading volume and price appreciation. The rating for the impact on investors specifically holding this stock is 8/10.

Difficult Terms Explained: Bonus Issue: A bonus issue is when a company gives its existing shareholders additional shares for free, based on the number of shares they already own. It's a way to reward shareholders and increase the number of shares in circulation without taking cash from the company.


Commodities Sector

Gold Prices Hold Near Record Highs, Awaiting Key Global Economic Triggers

Gold Prices Hold Near Record Highs, Awaiting Key Global Economic Triggers

Vedanta Launches CopperTech Metals to Boost Global Copper Production and Clean Energy Ambitions

Vedanta Launches CopperTech Metals to Boost Global Copper Production and Clean Energy Ambitions

Gold and Real Estate Emerge as Top Reliable Investment Assets in India

Gold and Real Estate Emerge as Top Reliable Investment Assets in India

India Poised to Become Rare-Earth Hub as Trade Reprieve Opens Window

India Poised to Become Rare-Earth Hub as Trade Reprieve Opens Window

Gold Prices Hold Near Record Highs, Awaiting Key Global Economic Triggers

Gold Prices Hold Near Record Highs, Awaiting Key Global Economic Triggers

Vedanta Launches CopperTech Metals to Boost Global Copper Production and Clean Energy Ambitions

Vedanta Launches CopperTech Metals to Boost Global Copper Production and Clean Energy Ambitions

Gold and Real Estate Emerge as Top Reliable Investment Assets in India

Gold and Real Estate Emerge as Top Reliable Investment Assets in India

India Poised to Become Rare-Earth Hub as Trade Reprieve Opens Window

India Poised to Become Rare-Earth Hub as Trade Reprieve Opens Window


Healthcare/Biotech Sector

Pfizer and Novo Nordisk in Bitter Bidding War for Metsera's Weight-Loss Drugs, Valued Over $10 Billion

Pfizer and Novo Nordisk in Bitter Bidding War for Metsera's Weight-Loss Drugs, Valued Over $10 Billion

Neuland Laboratories Reports Strong Q2 FY26 Earnings with 166% Profit Growth

Neuland Laboratories Reports Strong Q2 FY26 Earnings with 166% Profit Growth

Pfizer and Novo Nordisk in Bitter Bidding War for Metsera's Weight-Loss Drugs, Valued Over $10 Billion

Pfizer and Novo Nordisk in Bitter Bidding War for Metsera's Weight-Loss Drugs, Valued Over $10 Billion

Neuland Laboratories Reports Strong Q2 FY26 Earnings with 166% Profit Growth

Neuland Laboratories Reports Strong Q2 FY26 Earnings with 166% Profit Growth